UK Launches Trial Giving Volunteers Alternating Pfizer and AstraZeneca COVID-19 Vaccine Doses

MOSCOW (Sputnik) – The United Kingdom has launched recruitment for the world’s first clinical trial that will see volunteers given alternating doses of COVID-19 vaccines produced by AstraZeneca/Oxford University and Pfizer/BioNTech, the Department of Health and Social Care said Thursday.

“Backed by £7 million [$9.5 million] of government funding, the study will be the first in the world to determine the effects of using different vaccines for the first and second dose – for example, using Oxford University/AstraZeneca’s vaccine for the first dose, followed by Pfizer/BioNTech’s vaccine for the second”, the department said in a press release.

The study is being run by the National Immunisation Schedule Evaluation Consortium and will also assess the effects of giving participants a mixed-vaccine regimen at varying intervals.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button